New tools will advance study—and hopefully treatment—of common genetic heart conditions. For every 500 people reading this, one likely has a disease called hypertrophic cardiomyopathy (HCM). It is the most common genetic heart condition in the world, primarily caused by mutations that thicken heart muscle and, in rare cases, lead to heart failure and cardiac […]

QUEBEC CITY — Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, […]

GMP-compliant 50L and 250L SUPRs support large-scale recombinant antibody production Morgan Hill, USA and Delft, Netherlands: Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish life sciences products and solutions provider, today announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant […]

Twist joins leading AI stakeholders to help advance the development and deployment of safe, trustworthy AI under new U.S. Government safety institute SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the company has joined the U.S. AI […]

NEW YORK – Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences (“SOFIE” or the “Company”), a founder-led radiopharmacy and contract development and manufacturing organization. The investment was made in partnership with SOFIE’s founding team, who will retain a meaningful equity […]

The collaboration enables direct integration of AGU’s Sm@rtline Data Cockpit with the Genedata Biopharma Platform to automate and streamline process development workflows in GxP validated environments Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that they are entering into a strategic partnership with AGU, a leading provider […]

“When-issued” trading expected to begin on or about June 12, 2024 Record date for distribution of GRAIL shares will be June 13, 2024 Distribution date for GRAIL shares anticipated to be June 24, 2024 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is […]

CMP Scientific, a leader in capillary electrophoresis-mass spectrometry (CE-MS) technologies, is proud to announce the launch of its highly anticipated BioSummit™ CVA system at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. This state-of-the-art technology is set to revolutionize online charge variant analysis of recombinant protein therapeutics, offering unparalleled precision and robustness for […]

Collaboration leverages synergies of QIAGEN’s OmicSoft omics data through Evotec’s analysis platform PanHunter Customers accelerate target discovery decisions with high-quality multi-omic evidence, and expanded analysis capabilities Hamburg, Germany, and Venlo, the Netherlands — Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a […]

LGC has today announced that Marcus Kaeller will join its Board of Directors and Executive Leadership Team (ELT) as Chief Financial Officer (CFO), effective 3rd June 2024.  Marcus succeeds Vivid Sehgal, who will leave LGC after almost two and a half years of service.  Over the past several months, Vivid has worked closely with the LGC […]